(Q38058991)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

meta-analysis

0 references

title

The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Lei Yu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Jinke Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Yi Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Lina Hu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

English

0 references

publication date

9 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

391-396

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

A prognostic model for ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Future directions in the surgical management of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Hallmarks of Cancer: The Next Generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Tumor angiogenesis: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Endothelial progenitor cells: characterization and role in vascular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Tumor angiogenesis and accessibility: role of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

REporting recommendations for tumor MARKer prognostic studies (REMARK).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Beta blockade during and after myocardial infarction: an overview of the randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Role of lymphangiogenesis in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Incorporation of bevacizumab in the primary treatment of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

A phase 3 trial of bevacizumab in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Vascular endothelial growth factor pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Vascular endothelial growth factor serum concentrations in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Prechemotherapy Serum Levels of CD105, Transforming Growth Factor β2, and Vascular Endothelial Growth Factor Are Associated With Prognosis in Patients With Advanced Epithelial Ovarian Cancer Treated With Cytoreductive Surgery and Platinum-Based Chem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor beta and vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Vascular endothelial growth factor expression in early stage ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystoadenocarcinomas: relationship with MIB1 immunostaining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.11.002

10.1016/J.YGYNO.2012.11.002

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142075%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference